Healthcare Co., Ltd. (603313.SS)
CNY 6.79
(-0.59%)
CNY 6.79
(-0.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.11 Billion CNY | 1.73% |
| 2022 | 6.01 Billion CNY | -3.06% |
| 2021 | 6.2 Billion CNY | 83.43% |
| 2020 | 3.38 Billion CNY | 52.65% |
| 2019 | 2.21 Billion CNY | 48.65% |
| 2018 | 1.49 Billion CNY | 95.17% |
| 2017 | 763.81 Million CNY | 136.52% |
| 2016 | 322.94 Million CNY | -6.27% |
| 2015 | 344.55 Million CNY | 47.91% |
| 2014 | 232.94 Million CNY | 4.22% |
| 2013 | 223.51 Million CNY | 11.1% |
| 2012 | 201.19 Million CNY | 6.95% |
| 2011 | 188.12 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 6.15 Billion CNY | 2.94% |
| 2024 Q3 | 6.1 Billion CNY | -0.76% |
| 2024 Q1 | 5.97 Billion CNY | -2.29% |
| 2023 Q4 | 6.11 Billion CNY | -5.98% |
| 2023 Q2 | 6.32 Billion CNY | 3.74% |
| 2023 FY | 6.11 Billion CNY | 1.73% |
| 2023 Q1 | 6.1 Billion CNY | 1.45% |
| 2023 Q3 | 6.5 Billion CNY | 2.8% |
| 2022 Q1 | 6.17 Billion CNY | -0.54% |
| 2022 Q2 | 6.16 Billion CNY | -0.11% |
| 2022 Q3 | 6.32 Billion CNY | 2.62% |
| 2022 FY | 6.01 Billion CNY | -3.06% |
| 2022 Q4 | 6.01 Billion CNY | -4.93% |
| 2021 FY | 6.2 Billion CNY | 83.43% |
| 2021 Q4 | 6.2 Billion CNY | 16.72% |
| 2021 Q3 | 5.31 Billion CNY | 6.71% |
| 2021 Q2 | 4.98 Billion CNY | 7.52% |
| 2021 Q1 | 4.63 Billion CNY | 36.97% |
| 2020 FY | 3.38 Billion CNY | 52.65% |
| 2020 Q1 | 2.89 Billion CNY | 30.74% |
| 2020 Q2 | 3.07 Billion CNY | 6.16% |
| 2020 Q3 | 3.53 Billion CNY | 14.86% |
| 2020 Q4 | 3.38 Billion CNY | -4.25% |
| 2019 Q2 | 1.84 Billion CNY | 31.82% |
| 2019 Q4 | 2.21 Billion CNY | 15.65% |
| 2019 Q3 | 1.91 Billion CNY | 3.72% |
| 2019 Q1 | 1.4 Billion CNY | -6.0% |
| 2019 FY | 2.21 Billion CNY | 48.65% |
| 2018 Q2 | 738.17 Million CNY | 3.71% |
| 2018 Q4 | 1.49 Billion CNY | 28.6% |
| 2018 Q1 | 711.74 Million CNY | -6.82% |
| 2018 Q3 | 1.15 Billion CNY | 57.04% |
| 2018 FY | 1.49 Billion CNY | 95.17% |
| 2017 FY | 763.81 Million CNY | 136.52% |
| 2017 Q2 | 594.7 Million CNY | 21.57% |
| 2017 Q1 | 489.17 Million CNY | 51.47% |
| 2017 Q4 | 763.81 Million CNY | 12.45% |
| 2017 Q3 | 679.23 Million CNY | 14.21% |
| 2016 Q2 | 389.88 Million CNY | 0.0% |
| 2016 FY | 322.94 Million CNY | -6.27% |
| 2016 Q4 | 322.94 Million CNY | -24.63% |
| 2016 Q3 | 428.49 Million CNY | 9.9% |
| 2016 Q1 | - CNY | -100.0% |
| 2015 FY | 344.55 Million CNY | 47.91% |
| 2015 Q4 | 344.55 Million CNY | 0.0% |
| 2014 FY | 232.94 Million CNY | 4.22% |
| 2013 FY | 223.51 Million CNY | 11.1% |
| 2012 FY | 201.19 Million CNY | 6.95% |
| 2011 FY | 188.12 Million CNY | 0.0% |